Cooper Total Liabilities 2010-2024 | COO
Cooper total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Cooper total liabilities for the quarter ending July 31, 2024 were $4.183B, a 0.34% increase year-over-year.
- Cooper total liabilities for 2023 were $4.108B, a 4.86% decline from 2022.
- Cooper total liabilities for 2022 were $4.318B, a 62.06% increase from 2021.
- Cooper total liabilities for 2021 were $2.664B, a 8.53% decline from 2020.
Cooper Annual Total Liabilities
(Millions of US $) |
| 2023 |
$4,108 |
| 2022 |
$4,318 |
| 2021 |
$2,664 |
| 2020 |
$2,913 |
| 2019 |
$2,646 |
| 2018 |
$2,805 |
| 2017 |
$1,683 |
| 2016 |
$1,783 |
| 2015 |
$1,786 |
| 2014 |
$1,870 |
| 2013 |
$714 |
| 2012 |
$728 |
| 2011 |
$687 |
| 2010 |
$858 |
| 2009 |
$1,012 |
Cooper Quarterly Total Liabilities
(Millions of US $) |
| 2024-07-31 |
$4,183 |
| 2024-04-30 |
$4,244 |
| 2024-01-31 |
$4,337 |
| 2023-10-31 |
$4,108 |
| 2023-07-31 |
$4,169 |
| 2023-04-30 |
$4,162 |
| 2023-01-31 |
$4,225 |
| 2022-10-31 |
$4,318 |
| 2022-07-31 |
$4,469 |
| 2022-04-30 |
$4,764 |
| 2022-01-31 |
$4,736 |
| 2021-10-31 |
$2,664 |
| 2021-07-31 |
$2,825 |
| 2021-04-30 |
$2,851 |
| 2021-01-31 |
$2,932 |
| 2020-10-31 |
$2,913 |
| 2020-07-31 |
$2,988 |
| 2020-04-30 |
$2,883 |
| 2020-01-31 |
$2,818 |
| 2019-10-31 |
$2,646 |
| 2019-07-31 |
$2,557 |
| 2019-04-30 |
$2,661 |
| 2019-01-31 |
$2,873 |
| 2018-10-31 |
$2,805 |
| 2018-07-31 |
$3,030 |
| 2018-04-30 |
$3,226 |
| 2018-01-31 |
$3,112 |
| 2017-10-31 |
$1,683 |
| 2017-07-31 |
$1,690 |
| 2017-04-30 |
$1,810 |
| 2017-01-31 |
$1,837 |
| 2016-10-31 |
$1,783 |
| 2016-07-31 |
$1,855 |
| 2016-04-30 |
$1,856 |
| 2016-01-31 |
$1,795 |
| 2015-10-31 |
$1,786 |
| 2015-07-31 |
$1,729 |
| 2015-04-30 |
$1,777 |
| 2015-01-31 |
$1,819 |
| 2014-10-31 |
$1,870 |
| 2014-07-31 |
$691 |
| 2014-04-30 |
$660 |
| 2014-01-31 |
$661 |
| 2013-10-31 |
$714 |
| 2013-07-31 |
$569 |
| 2013-04-30 |
$630 |
| 2013-01-31 |
$720 |
| 2012-10-31 |
$728 |
| 2012-07-31 |
$787 |
| 2012-04-30 |
$591 |
| 2012-01-31 |
$662 |
| 2011-10-31 |
$687 |
| 2011-07-31 |
$728 |
| 2011-04-30 |
$815 |
| 2011-01-31 |
$850 |
| 2010-10-31 |
$858 |
| 2010-07-31 |
$909 |
| 2010-04-30 |
$966 |
| 2010-01-31 |
$969 |
| 2009-10-31 |
$1,012 |
| 2009-07-31 |
$1,067 |
| 2009-04-30 |
$1,118 |
| 2009-01-31 |
$1,172 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$18.348B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
